Search

The ability to publish research papers is a must for scientists nowadays. Ideally, at the very beginning of their career, young researchers, PhD students, should be instructed in writing research papers and should get feedback on their texts. In this study, the first manuscripts from 22 doctoral students, non-native English speakers, 223 pages were analysed for errors in grammar, spelling, punctuation, and style. For each type of error and each student, the average per page was calculated. The most frequent errors were identified in using articles, formal features, missing information, and the use of inappropriate words. Individual students showed significantly different levels, which reflected their previous language training and the approach (responsibility) to completing the task. The results will be used to modify the course in Academic Writing (more attention paid to the most frequent errors) and individual work with students. [ABSTRACT FROM AUTHOR]

Despite incredible growth in systems of care and rapidly expanding therapeutic options for people with inflammatory bowel disease, there are significant barriers that prevent patients from benefiting from these advances. These barriers include restrictions in the form of prior authorization, step therapy, and prescription drug coverage. Furthermore, inadequate use of multidisciplinary care and inflammatory bowel disease specialists limits patient access to high-quality care, particularly for medically vulnerable populations. However, there are opportunities to improve access to high-quality, patient-centered care. This position statement outlines the policy and advocacy goals that the American Gastroenterological Association will prioritize for collaborative efforts with patients, providers, and payors. [ABSTRACT FROM AUTHOR]

Bibliometric analysis of highly cited papers facilitates researchers in formulating strategic research possibilities and addressing gaps in specific domains. In this context, a bibliometric analysis was conducted to identify published papers on "oral mucosal lesions in COVID-19" within medical literature. A comprehensive search was performed in the Scopus database in July 2023. Relevant articles were retrieved, reviewed, and data for the bibliometric analysis was recorded. Network visualization of authors, countries, and keywords was generated using VOSviewer software. The analyzed articles were published over the last three years, from 2020 to 2023, with the highest output observed in 2021. The citation count for individual papers ranged from 1 to 340, with a mean of 22.325 ± 58.93 citations. A total of 37 journals were involved in publishing papers on this topic, and five authors each contributed three papers. Notably, Brazil made the highest number of contributions with eight papers. Among the 40 papers, 19 were review papers and 16 were articles discussing various aspects of oral mucosal lesions in COVID-19 patients. Additionally, six papers were identified as systematic reviews, designated with a high level of evidence. This study presents a comprehensive bibliometric analysis of papers published on "oral mucosal lesions in COVID-19." The findings will assist researchers in identifying impactful papers, understanding the prevailing research trends, and guiding future research directions in this domain. The insights gained from this analysis can contribute significantly to advancing knowledge and improving patient care in this critical area of study. • First comprehensive bibliometric analysis on "oral mucosal lesions in COVID-19" in medical literature. • Offers valuable insights to researchers for strategic planning and further exploration in this domain. • Thoroughly examined articles from 2020 to 2023, with a peak in output observed in 2021. • Six systematic reviews among 40 papers, indicating high-quality evidence-based studies. • Brazil emerged as the top contributor with eight papers on the subject. [ABSTRACT FROM AUTHOR]

Extant studies have focused on exploring the research output of universities in Nigeria, but the measure of the quality of research output using citations per paper (CPP) from the Web of Science (WoS) and Scopus is scarcely discussed. This paper investigated the quality of papers published by the top 76 universities in Nigeria. Five hypotheses on CPP were tested using Kruskal-Wallis and Mann-Whitney tests. These hypotheses tested whether CPP is the same or different i) across six geo-political regions (GPRs), ii) between the two major regions, iii) across three university funding types, iv) in Scopus and WoS, and v) if these two databases are correlated. Results using these two databases indicated that no significant median differences were detected among universities across the six GPRs, between northern and southern Nigeria, and between the three funding types (federal, state, and private). Moreover, no significant median differences in CPP between Scopus and WoS were detected, and CPP in both databases was highly positively correlated (0.879; p = 0.05). A comparison of the mean CPP of Nigeria (5.90) from Scopus with 57 other African countries ranked it 47th despite being ranked third in terms of volume of published articles. Policy prescriptions are made on the implications of using CPP for practice. [ABSTRACT FROM AUTHOR]

The Qur'an is a linguistic miracle that was revealed in the Arabic language to mankind. However, not everyone can fully understand this divine revelation as Arabic is not everyone's mother tongue. Therefore, to facilitate non-native Arabic speakers to understand the Qur'an, many efforts have been made, including in studying the concepts that are present in the Qur'an, through for example, the Izutsu's approach (IA) (to investigate the semantic structure of the Qur'an) and the Conceptual Metaphor Theory (CMT) (to investigate the figurative language). While these two approaches have been helpful in assisting individuals to understand the Qur'an, studies that investigate the connection between the two approaches are still lacking. In addition previous research that used either one of the approaches sometimes lack dependency on the exegesis (tafsirs) of the Qur'an; as a result, such studies become less comprehensive. Thus, this conceptual paper proposes how the combination of these two approaches can be used to achieve a better understanding of the concepts stated in the Qur'an The concept of حُبّ HUBB (LOVE) is used to achieve this aim. [ABSTRACT FROM AUTHOR]

Copyright of Canadian Journal of Dental Hygiene is the property of Canadian Dental Hygienists Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The 1983 Orphan Drug Act in the United States (US) changed the landscape for development of therapeutics for rare or orphan diseases, which collectively affect approximately 300 million people worldwide, half of whom are children. The act has undoubtedly accelerated drug development for orphan diseases, with over 6,400 orphan drug applications submitted to the US Food and Drug Administration (FDA) from 1983 to 2023, including 350 drugs approved for over 420 indications. Drug development in this population is a global and collaborative endeavor. This position paper of the International Society for Central Nervous System Clinical Trials and Methodology (ISCTM) describes some potential best practices for the involvement of key stakeholder feedback in the drug development process. Stakeholders include advocacy groups, patients and caregivers with lived experience, public and private research institutions (including academia and pharmaceutical companies), treating clinicians, and funders (including the government and independent foundations). The authors articulate the challenges of drug development in orphan diseases and propose methods to address them. Challenges range from the poor understanding of disease history to development of endpoints, targets, and clinical trials designs, to finding solutions to competing research priorities by involved parties. [ABSTRACT FROM AUTHOR]